Gene · 6612
Papers1,564
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,564
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Association of Lifestyle-Induced Weight Loss With Gene Expression in Subcutaneous Adipose Tissue in Metabolic Syndrome. | J Diabetes | 2025 | 40229590 | PubTator, text mining | PubMed |
| Exploring the modulation of phosphorylation and SUMOylation-dependent NPR1 conformational switching on immune regulators TGA3 and WRKY70 through molecular simulation. | Plant Physiol Biochem | 2025 | 40056739 | PubTator, text mining | PubMed |
| Chemical approaches to explore ubiquitin-like proteins. | RSC Chem Biol | 2025 | 39950163 | PubTator, text mining | PubMed |
| Redox regulation of TRIM28 facilitates neuronal ferroptosis by promoting SUMOylation and inhibiting OPTN-selective autophagic degradation of ACSL4. | Cell Death Differ | 2025 | 39875520 | PubTator, text mining | PubMed |
| Viral RNA polymerase as a SUMOylation decoy inhibits RNA quality control to promote potyvirus infection. | Nat Commun | 2025 | 39747035 | PubTator, text mining | PubMed |
| The 2 faces of plant SUMOylation against viruses. | PLoS Pathog | 2024 | 39689138 | PubTator, text mining | PubMed |
| Recent Advances on the Regulations of Organic Anion Transporters. | Pharmaceutics | 2024 | 39598479 | PubTator, text mining | PubMed |
| β-catenin-inhibited Sumoylation modification of LKB1 and fatty acid metabolism is critical in renal fibrosis. | Cell Death Dis | 2024 | 39438470 | PubTator, text mining | PubMed |
| The role of SUMOylation in biomolecular condensate dynamics and protein localization. | Cell Insight | 2024 | 39399482 | PubTator, text mining | PubMed |
| Dysregulated gene expression of SUMO machinery components induces the resistance to anti-PD-1 immunotherapy in lung cancer by upregulating the death of peripheral blood lymphocytes. | Front Immunol | 2024 | 39211047 | PubTator, text mining | PubMed |
| SUMO3 inhibition by butyric acid suppresses cell viability and glycolysis and promotes gemcitabine antitumor activity in pancreatic cancer. | Biol Direct | 2024 | 39183358 | PubTator, text mining | PubMed |
| Single-cell landscape of alternative polyadenylation in human lymphoid hematopoiesis. | J Mol Cell Biol | 2024 | 38982223 | PubTator, text mining | PubMed |
| Unconventional posttranslational modification in innate immunity. | Cell Mol Life Sci | 2024 | 38970666 | PubTator, text mining | PubMed |
| Expression of SUMO and NF-κB genes in hepatitis B virus-associated hepatocellular carcinoma patients: An observational study. | Medicine (Baltimore) | 2024 | 38941371 | PubTator, text mining | PubMed |
| SUMOylated Golgin45 associates with PML-NB to transcriptionally regulate lipid metabolism genes during heat shock stress. | Commun Biol | 2024 | 38710927 | PubTator, text mining | PubMed |
| SUMOylation controls Hu antigen R posttranscriptional activity in liver cancer. | Cell Rep | 2024 | 38507413 | PubTator, text mining | PubMed |
| Molecular Organization and Regulation of the Mammalian Synapse by the Post-Translational Modification SUMOylation. | Cells | 2024 | 38474384 | PubTator, text mining | PubMed |
| SumoPred-PLM: human SUMOylation and SUMO2/3 sites Prediction using Pre-trained Protein Language Model. | NAR Genom Bioinform | 2024 | 38327870 | PubTator, text mining | PubMed |
| Mechanisms and functions of SUMOylation in health and disease: a review focusing on immune cells. | J Biomed Sci | 2024 | 38280996 | PubTator, text mining | PubMed |
| Regulating Androgen Receptor Function in Prostate Cancer: Exploring the Diversity of Post-Translational Modifications. | Cells | 2024 | 38275816 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6612/papers?page=2